Print this page KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the first-line treatment of patients with stage III non-small cell lung cancer (NSCLC) who are not… Read More »
Wales to become a ‘global player’ in cancer treatment as pioneering centre opens offering proton beam that saved Ashya King to NHS patients The first UK centre using the method was officially opened today Rutherford Cancer Centre has been treating cancer patients since April 2018 Ryan Scott, 23, is the first NHS Wales patient to… Read More »
This 16-Year-Old Couldn’t Find Relief for His Arthritis Pain—So He Invented His Own Treatment | Reader’s Digest Skip links Reader's Digest
Turkey provides cutting-edge medical services, including stem cell transplants, to millions – including the refugees it hosts – said a Turkish professor of hematology. Fevzi Altuntaş told Anadolu Agency (AA) that Turkey emulated developed countries in the West in its drive to offer patients high-end medical services. Altuntaş, founder of Turkish cord blood and bone… Read More »
Print this page Basel, Switzerland, February 13, 2019 – Novartis announced today that the US Food and Drug Administration (FDA) has approved Egaten (triclabendazole) for the treatment of fascioliasis in patients six years of age and older. This makes Egaten the only FDA-approved drug for people with this disease and is expected to facilitate broader… Read More »